Featuring an interview with Dr Stephen V Liu, including the following topics:
- Management of localized non-small cell lung cancer (NSCLC) (0:00)
- First-line treatment of advanced NSCLC (10:53)
- Targeted therapy for patients with NSCLC and actionable genomic alterations (30:24)
- Recent FDA approvals for NSCLC (37:49)
- Recent advances in small cell lung cancer (47:14)
- Lurbinectidin in combination with atezolizumab as front-line maintenance therapy for patients with early-stage SCLC (52:33)
CME information and select publications